Exclusion Criteria:~* Immune therapy targeting Alzheimer beta amyloid within the last 12 months~*
Institutionalized~* Disability that may prevent completion of all study requirements (e.g., blindness,
deafness, or communication difficulty)~* Reported use of tobacco products in the previous 3 months or have a
urine cotinine level greater than 500 ng/ml~* Past medical history of clinically significant electrocardiogram
(ECG) abnormalities or a family history (grandparents, parents, and siblings) of prolonged QT-interval
syndrome~* History or current diagnosis of conditions specified in the protocol.~Other protocol-defined
inclusion/exclusion criteria may apply.
